Clinical case of infertility treatment and pregnancy and delivery management following uterine artery embolization for uterine fibroids
- Authors: Zuev V.M.1,2, Lisitsyna O.I.2, Kalinina E.А.2, Goncharenko N.V.1,2, Murashko A.V.1, Dzhibladze T.A.1,2, Khokhlova I.D.1, Baburin D.V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- ART-ECO Reproductive Health Clinic
- Pages: 255-263
- Section: Clinical case reports
- Submitted: 24.12.2024
- Accepted: 14.01.2025
- Published: 11.04.2025
- URL: https://archivog.com/2313-8726/article/view/643370
- DOI: https://doi.org/10.17816/aog643370
- EDN: https://elibrary.ru/RTYFTE
- ID: 643370
Cite item
Abstract
Uterine artery embolization is a minimally invasive and effective method for treating symptomatic uterine fibroids; however, its impact on fertility, pregnancy course, and obstetric outcomes remains a topic of ongoing debate.
This article presents a clinical case involving the management of a patient with infertility due to uterine factors following uterine artery embolization, which was complicated by non-target embolization of the ovarian vessels. After specialized laser spectral diagnostics of endometrial status and restorative treatment, the patient achieved a spontaneous pregnancy. The pregnancy was complicated by the threat of miscarriage, cervical insufficiency, premature detachment of a normally located placenta, and preterm delivery at 32–33 weeks, as well as prolonged postpartum vaginal bleeding.
Additional studies are needed to investigate long-term reproductive outcomes in women following uterine artery embolization and to develop diagnostic and preventive approaches aimed at reducing the risk of complications. The results of this study may contribute to improving the management strategies for patients with similar complications and serve as a basis for developing treatment guidelines.
Full Text

About the authors
Vladimir M. Zuev
I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic
Author for correspondence.
Email: vlzuev@bk.ru
ORCID iD: 0000-0001-8715-2020
SPIN-code: 2857-0309
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Moscow; MoscowOlga I. Lisitsyna
ART-ECO Reproductive Health Clinic
Email: o_yazykova@inbox.ru
ORCID iD: 0000-0002-7775-3508
SPIN-code: 5211-4258
Russian Federation, Moscow
Elena А. Kalinina
ART-ECO Reproductive Health Clinic
Email: kalinina@art-ivf.ru
ORCID iD: 0000-0002-1273-8358
MD, Dr. Sci. (Medicine)
Russian Federation, MoscowNataliya V. Goncharenko
I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic
Email: goncharenko_n_v@staff.sechenov.ru
ORCID iD: 0000-0003-2925-1260
Russian Federation, Moscow; Moscow
Andrey V. Murashko
I.M. Sechenov First Moscow State Medical University
Email: murashkoa@mail.ru
ORCID iD: 0000-0003-0663-2909
SPIN-code: 2841-9638
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowTea A. Dzhibladze
I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic
Email: djiba@bk.ru
ORCID iD: 0000-0003-1540-5628
SPIN-code: 5688-1084
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Moscow; MoscowIrina D. Khokhlova
I.M. Sechenov First Moscow State Medical University
Email: irhohlova5@gmail.com
ORCID iD: 0000-0001-8547-6750
SPIN-code: 6858-5235
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, MoscowDmitrii V. Baburin
I.M. Sechenov First Moscow State Medical University
Email: baburin_d_v@staff.sechenov.ru
ORCID iD: 0000-0003-2398-3348
SPIN-code: 3264-0730
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowReferences
- Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021;137(6):e100–e115. doi: 10.1097/AOG.0000000000004401
- Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99
- Kubik-Huch RA, Weston M, Nougaret S, et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol. 2018;28(8):3125–3137. doi: 10.1007/s00330-017-5157-5
- Mas A, Tarazona M, Dasí Carrasco J, et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607–617. doi: 10.2147/IJWH.S138982
- Czuczwar P, Stepniak A, Milart P, et al. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve — an observational study. J Ovarian Res. 2018;11(1):45. doi: 10.1186/s13048-018-0420-1
- Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324–330. doi: 10.1016/j.fertnstert.2009.02.069
- Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31(1):73–85. doi: 10.1007/s00270-007-9195-2
- Zanolli NC, Bishop KC, Kuller JA, et al. Fibroids and fertility: a comparison of myomectomy and uterine artery embolization on fertility and reproductive outcomes. Obstet Gynecol Surv. 2022;77(8):485–494. doi: 10.1097/OGX.0000000000001052
- Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191(1):18–21. doi: 10.1016/j.ajog.2004.01.046
- Ziganshin AM, Dikke GB, Yanbarisova AR, et al. Experience of managing pregnancy after in vitro fertilization and its outcome in a patient with uterine leiomyoma and a history of uterine artery embolization. Obstetrics and Gynecology. 2024;(11):229–234. doi: 10.18565/aig.2024.275 EDN: BSXJVB
- Savelyeva GM, Krasnova IA, Breusenko VG, et al. The efficiency of EMA and prevention of its possible complications in the treatment of myoma. Obstetrics and Gynecology. 2014;(11):74–79. EDN: TAZJTR
- Kalmykov EL, Rakhimov FR, Umarzoda SG, Baratov AK. Uterine artery embolization for uterine leiomyoma: the state of the problem. Obstetrics and Gynecology. 2020;(9):18–26. doi: 10.18565/aig.2020.9.18-26 EDN: SLPJDJ
- Zuev VM, Kalinina EA, Kukushkin VI, et al. Innovative laser technologies in the diagnosis and treatment of the endometrium of concern in reproductive medicine. Obstetrics and Gynecology. 2020;(4):157–165. doi: 10.18565/aig.2020.4.157-165 EDN: IQOFPF
- Ravina JH, Ciraru-Vigneron N, Bouret JM, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–672. doi: 10.1016/S0140-6736(95)92282-2
- Ryu RK, Chrisman HB, Omary RA, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol. 2001;12(9):1071–1074. doi: 10.1016/S1051-0443(07)61594-2
- Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol. 2013;24(4):459–467. doi: 10.1016/j.jvir.2012.12.002
- Amato P, Roberts AC. Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril. 2001;75(2):438–439. doi: 10.1016/s0015-0282(00)01678-2
- Wolanske KA, Gordon RL, Wilson MW, et al. Coil embolization of a tuboovarian anastomosis before uterine artery embolization to prevent nontarget particle embolization of the ovary. J Vasc Interv Radiol. 2003;14(10):1333–1338. doi: 10.1097/01.RVI.0000092906.31640
- Liu J-L, Liang Z-H, Cui B, et al. Impact of uterine artery embolization on ovarian function and pregnancy outcome after uterine-fibroids treatment: A prospective study. World J Clin Cases. 2024;12(15):2551–2559. doi: 10.12998/wjcc.v12.i15.2551
- El Shamy T, Amer SAK, Mohamed AA, et al. The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2020;99(1):16–23. doi: 10.1111/aogs.13698
- Tropeano G, Litwicka K, Di Stasi C, et al. Permanent amenorrhea associated with endometrial atrophy after uterine artery embolization for symptomatic uterine fibroids. Fertil Steril. 2003;79(1):132–135. doi: 10.1016/S0015-0282(02)04400-X
- Peng J, Wang J, Shu Q, et al. Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids. Sci Rep. 2024;14(1):19252. doi: 10.1038/s41598-024-69754-0
- Dzhibladze TA, Zuev VM, Ishchenko AI, et al. Complication treatment for uterine factor infertility in Asherman’s syndrome. Obstetrics and Gynecology. 2022;(3):165–169. doi: 10.18565/aig.2022.3.165-169 EDN: NJKLKW
- Fang Z, Huang J, Mao J, et al. Effect of endometrial thickness on obstetric and neonatal outcomes in assisted reproduction: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):55. doi: 10.1186/s12958-023-01105-6
- Choo S, Wiseman D, MacMillan JB, Gratton R. Myometrial defect in a subsequent pregnancy after uterine artery embolization for postpartum hemorrhage, in the absence of leiomyomas or previous uterine surgery. J Obstet Gynaecol Can. 2020;42(2):173–176. doi: 10.1016/j.jogc.2019.04.013
- Yan X, Zhou L, He G, Liu X. Pregnancy rate and outcomes after uterine artery embolization for women: a systematic review and meta-analysis with trial sequential analysis. Front Med (Lausanne). 2023;10:1283279. doi: 10.3389/fmed.2023.1283279
Supplementary files
